Current Problems in Diagnostic Radiology
Volume 35, Issue 6 , Pages 219-223 , November 2006

High-Resolution Computed Tomographic Imaging and Pathologic Features of Pulmonary Veno-Occlusive Disease: A Review of Three Patients

  • Aliye A. Ozsoyoglu

      Affiliations

    • Case Western Reserve University School of Medicine, Cleveland, OH
    • ,
  • Justin Swartz, MD

      Affiliations

    • Division of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Carol F. Farver, MD

      Affiliations

    • Division of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Tan-Lucien H. Mohammed, MD, FCCP

      Affiliations

    • Section of Thoracic Imaging, Division of Radiology, Cleveland Clinic Foundation, Cleveland, OH.
    • Corresponding Author InformationReprint requests: Tan-Lucien H. Mohammed, MD, FCCP, Section of Thoracic Imaging, Division of Radiology/Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland OH 44195.

References 

  1. Höra J. Zur Histologie der klinischen “Primaren Pulmonalsklerose.”. Frankf Z Pathol. 1934;47:100–118
  2. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111–117
  3. Holcomb BW, Loyd JE, Ely WE, et al. Pulmonary veno-occlusive disease: A case series and new observations. Chest. 2000;118:1671–1679
  4. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000;162:1964–1973
  5. Runo JR, Vnencak-Jones CL, Prince M, et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med. 2003;167:889–894
  6. Swensen SJ, Tashjian JH, Myers JL, et al. Pulmonary venoocclusive disease: CT findings in eight patients. AJR. 1996;167:937–940
  7. Cassart M, Gevenois PA, Kramer M, et al. Pulmonary venoocclusive disease: CT findings before and after single-lung transplantation. Ajr. 1993;160:759–760
  8. Bailey CL, Channick RN, Auger WR, et al. High probability perfusion lung scans in pulmonary venoocclusive disease. Am J Respir Crit Care Med. 2000;162:1974–1978
  9. Hoeper MM, Schwarze M, Ehlerding S, et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med. 2000;342:1866–1870
  10. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425–1436
  11. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation. 2002;106:1477–1482
  12. Okumura H, Nagaya N, Kyotani S, et al. Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease. Chest. 2002;122:1096–1098
  13. Palmer SM, Robinsom LJ, Wang A, et al. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. 1998;113:237–240
  14. Resten A, Maitre S, Humbert M, et al. Pulmonary arterial hypertension: Thin-section CT predictors of epoprostenol therapy failure. Radiology. 2002;222:782–788
  15. Resten A, Maitre S, Humbert M, et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR. 2004;183:65–70
  16. Wagenvoort CA, Wagenvoort N. The pathology of pulmonary veno-occlusive disease. Virchows Arch A Pathol Anat Histol. 1974;364:69–79
  17. Dufour B, Maitre S, Humbert M, et al. High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease. AJR. 1998;171:1321–1324

PII: S0363-0188(06)00049-1

doi: 10.1067/j.cpradiol.2006.07.004

Current Problems in Diagnostic Radiology
Volume 35, Issue 6 , Pages 219-223 , November 2006

Article Tools

* Image Usage & Resolution